Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
176.05
+0.77 (0.44%)
At close: Nov 19, 2024, 4:00 PM
179.95
+3.90 (2.22%)
Pre-market: Nov 20, 2024, 6:08 AM EST
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for INSP stock have an average target of 226.18, with a low estimate of 185 and a high estimate of 260. The average target predicts an increase of 28.47% from the current stock price of 176.05.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for INSP stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 2 | 2 | 2 |
| Buy | 6 | 6 | 6 | 6 | 6 | 5 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 13 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $260 | Buy | Reiterates | $260 | +47.69% | Nov 5, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $255 → $260 | Buy | Reiterates | $255 → $260 | +47.69% | Nov 5, 2024 |
| Stifel | Stifel | Hold Reiterates $170 → $200 | Hold | Reiterates | $170 → $200 | +13.60% | Nov 5, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $187 → $198 | Hold | Maintains | $187 → $198 | +12.47% | Nov 5, 2024 |
| Baird | Baird | Buy Maintains $240 → $252 | Buy | Maintains | $240 → $252 | +43.14% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
812.01M
from 624.80M
Increased by 29.96%
Revenue Next Year
969.67M
from 812.01M
Increased by 19.42%
EPS This Year
1.35
from -0.72
EPS Next Year
2.02
from 1.35
Increased by 49.20%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 838.2M | 1.0B | 1.2B | ||
| Avg | 812.0M | 969.7M | 1.1B | ||
| Low | 777.1M | 907.0M | 1.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 34.2% | 25.0% | 25.2% | ||
| Avg | 30.0% | 19.4% | 18.2% | ||
| Low | 24.4% | 11.7% | 9.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.47 | 2.59 | 4.82 | ||
| Avg | 1.35 | 2.02 | 3.20 | ||
| Low | 1.18 | 1.47 | 2.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 92.0% | 139.1% | ||
| Avg | - | 49.2% | 58.9% | ||
| Low | - | 8.8% | 9.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.